Related Experiment Video
Updated: Mar 19, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation
Na Xie1, Kefei Yuan1, Li Zhou1,2
1a State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy , Chengdu , China.
Abstract:
Adenosine monophosphate-activated protein kinase (AMPK) is a crucial energy sensor that maintains cellular energy homeostasis. AMPK plays a critical role in macroautophagy/autophagy, and autophagy facilitates hepatitis B virus (HBV) replication. To date, the intrinsic link among AMPK, autophagy and HBV production remains to be elucidated. Here, we demonstrate that PRKAA (a catalytic subunit of AMPK) is activated in response to HBV-induced oxidative stress, which in turn decreases the production of HBV. Mechanistic studies reveal that the autophagy machinery is associated with the inhibitory effect of PRKAA/AMPK on HBV production. Activation of PRKAA/AMPK promotes autolysosome-dependent degradation through stimulation of cellular ATP levels, which then leads to the depletion of autophagic vacuoles. Taken together, our data suggest that the activation of AMPK might be a stress response of host cells to restrict virus production through promotion of autophagic degradation. These findings therefore indicate that AMPK could provide a potential therapeutic target for HBV infection.
Insights
Activation of Adenosine monophosphate-activated protein kinase (AMPK) combats Hepatitis B virus (HBV) replication. AMPK triggers autophagy-dependent degradation, reducing HBV production and offering a potential therapeutic strategy for HBV infection.
Area of Science:
- Hepatology
- Cellular Biology
- Virology
Background:
- Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis.
- Autophagy, a cellular degradation process, is known to facilitate Hepatitis B virus (HBV) replication.
- The precise relationship between AMPK, autophagy, and HBV production is not fully understood.
Purpose of the Study:
- To investigate the role of AMPK in HBV production.
- To elucidate the mechanisms by which AMPK influences HBV replication.
- To explore the potential of AMPK as a therapeutic target for HBV infection.
Main Methods:
- Activation of PRKAA (AMPK catalytic subunit) in response to HBV-induced oxidative stress.
- Assessment of HBV production levels following AMPK activation.
- Mechanistic studies involving autophagy machinery and cellular ATP levels.
Main Results:
- PRKAA/AMPK activation was observed in response to HBV-induced oxidative stress.
- AMPK activation led to a decrease in HBV production.
- AMPK activation promoted autolysosome-dependent degradation, depleting autophagic vacuoles and inhibiting HBV.
Conclusions:
- AMPK activation serves as a host cell stress response to restrict HBV production via enhanced autophagic degradation.
- The findings highlight a novel mechanism linking AMPK, autophagy, and HBV inhibition.
- AMPK represents a promising therapeutic target for managing HBV infection.
Related Concept Videos
Hepatitis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Inhibitors of Viral Protein Synthesis
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Viruses with RNA Genomes

